Metabolite Profiling for Faster Microorganism Identification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying microorganisms and determining their sensitivity to toxic substances, such as antibiotics, are time-consuming, typically taking 2-4 days due to the need for microbial cultures to grow, which delays effective antibiotic therapy and increases morbidity and mortality in infections.

Innovation Solution

A method involving culturing samples in growth media containing specific metabolites, analyzing the cultured medium for unique metabolite concentrations, and using mass spectrometry to identify cell types and toxin sensitivity within hours, reducing the identification and sensitivity testing time to approximately half.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If current chemical tests or spectrometric methods are used for microorganism identification, then identification can be performed with existing technology, but it takes 2-4 days due to culture time requirements

Engineering Contradiction:
Improveidentification timeVSAvoidtesting throughput
Core Design Contradiction:
Loss of timeVSProductivity

Solution Approach 1:

The patent applies preliminary action by performing metabolic analysis on microorganisms during the culture growth phase itself, rather than waiting for culture completion. The system continuously monitors metabolic byproducts (such as acid production, gas formation, and nutrient consumption) throughout the culture process, enabling identification to occur concurrently with growth rather than after growth completes. This reduces the total time from sample receipt to identification result.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses metabolic byproducts as intermediary substances that indicate microorganism identity. Instead of directly analyzing the microorganism itself after culture completion, the system detects intermediate metabolic products (acids, gases, consumed nutrients) that are produced during growth. These intermediaries provide real-time information about the microorganism's identity and antibiotic susceptibility without requiring wait for full culture development.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If traditional culture methods are used, then microorganism growth can be observed, but the process is too slow for timely antibiotic therapy initiation

Engineering Contradiction:
Improveidentification accuracyVSAvoidtime to therapy initiation
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent replaces the mechanical observation of culture growth (visual inspection of colony formation) with instrumental detection of metabolic activity. Instead of waiting for visible colony growth and then performing additional tests, the system uses sensors and analytical instruments to detect metabolic byproducts, nutrient consumption, and gas production in real-time. This substitution enables reliable identification and susceptibility testing during the growth phase itself, reducing time to therapy initiation while maintaining accuracy.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Productivity

If metabolite analysis is performed in growth medium, then identification and sensitivity testing can be completed faster, but requires analysis of consumed and produced metabolites

Engineering Contradiction:
Improvetesting speedVSAvoidanalysis system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent applies universality by using a single integrated system that performs multiple functions: it monitors metabolic byproducts for identification, tests antibiotic susceptibility, and tracks growth kinetics all simultaneously. The same metabolic analysis platform that detects organism identity also determines antibiotic sensitivity by observing changes in metabolic activity in the presence of antibiotics. This multi-functionality increases productivity without proportionally increasing device complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system applies self-service by using the microorganism's own metabolic activity as the test signal. The microorganism produces and consumes metabolites that naturally indicate its identity and physiological state. By monitoring these self-generated signals, the system obtains identification and susceptibility information without requiring additional reagents, stains, or complex sample preparation. The microorganism essentially tests itself through its metabolic behavior.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid identification of microorganisms and determination of their sensitivity to toxins in approximately half the time of current practices, improving patient outcomes by accelerating effective antibiotic therapy.

Implementation Method 1

analysing the cultured growth medium by mass spectrometry

Methodology Applied
Scientific EffectMass spectrometry:

Data Source

PatentUS12503719B2Metabolomic characterization of microorganisms
Publication Date: 2025.12.23 LEWIS IAN ANDREW
  • US12503719B2 patent drawing
  • US12503719B2 patent drawing
  • US12503719B2 patent drawing

AI summary

Methods and systems are for identifying the cell type of an unknown microorganism. The device includes: an apparatus for culturing unknown organism(s), a diagnostic data acquisition tool and a computer program. The method includes: incubation of the sample with a growth medium (with or without toxins), and an analysis of the metabolites detected in the sample. The computer system compares the results collected from the device to reference metabolite profiles.